Intelligent Medicine Acquisition Corp. (IQMDW)
Intelligent Medicine Acquisition Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in Bethesda, MD, US. The stock last traded at $0.00, down 91.78% on the session, giving a market capitalisation of $0. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.
Intelligent Medicine Acquisition Corp. is primarily dedicated to executing a major business transaction, which could involve a merger, an asset acquisition, a stock purchase, a capital stock exchange, or a corporate restructuring, with one or more other entities. The firm specifically seeks out prospective ventures and opportunities within the life sciences sector. Established in 2021, its corporate headquarters are situated in Bethesda, Maryland.